Chuanhui Dong Selected Research

Apolipoproteins

3/2018	Apolipoprotein E Gene Polymorphism and Subclinical Carotid Atherosclerosis: The Northern Manhattan Study.
1/2017	MRI Markers Predict Cognitive Decline Assessed by Telephone Interview: The Northern Manhattan Study.
11/2016	APOE ε4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chuanhui Dong Research Topics

Disease

22	Stroke (Strokes) 11/2023 - 01/2011
8	Ischemic Stroke 10/2023 - 04/2014
6	Atherosclerosis 10/2023 - 12/2014
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2008
3	Obesity 01/2022 - 09/2004
2	Noma (Nomas) 05/2024 - 07/2011
2	Dyslipidemias (Dyslipidemia) 02/2023 - 01/2022
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 11/2016
2	Cognitive Dysfunction 01/2017 - 11/2016
2	Chronic Renal Insufficiency 09/2015 - 05/2014
2	Major Depressive Disorder (Major Depressive Disorders) 12/2014 - 02/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2014 - 09/2014
2	Tremor (Tremors) 07/2012 - 10/2011
2	Essential Tremor (Essential Tremors) 07/2012 - 10/2011
2	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2012 - 05/2012
2	Type 2 Diabetes Mellitus (MODY) 12/2008 - 09/2004
2	Insulin Resistance 12/2008 - 03/2005
1	Hyperlipidemias (Hyperlipidemia) 10/2023
1	Heart Failure 02/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2023
1	Hematoma 10/2022
1	Cerebral Hemorrhage 10/2022
1	Hyperalgesia 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Malignant Hyperthermia 01/2019
1	Neuralgia (Stump Neuralgia) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Chronic Pain 01/2019
1	Carotid Artery Diseases 03/2018
1	Aneurysm (Aneurysms) 01/2018
1	Ganglion Cysts (Ganglion) 01/2018
1	Vascular Remodeling 01/2018
1	Multiple Sclerosis 08/2017
1	Parkinson Disease (Parkinson's Disease) 08/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Kidney Diseases (Kidney Disease) 10/2016
1	Neoplasms (Cancer) 02/2016
1	Glioma (Gliomas) 02/2016
1	Erectile Dysfunction 01/2016
1	Heart Diseases (Heart Disease) 12/2014

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2011
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2004
3	Mitochondrial Uncoupling ProteinsIBA 05/2024 - 01/2011
3	SirtuinsIBA 05/2024 - 01/2011
3	LipidsIBA 01/2022 - 07/2011
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2017
3	Apolipoproteins E (ApoE)IBA 03/2018 - 11/2016
3	ApolipoproteinsIBA 03/2018 - 11/2016
3	Fibroblast Growth Factor-23IBA 04/2016 - 05/2014
3	Phosphates (Orthophosphate)IBA 04/2016 - 05/2014
2	Antihypertensive Agents (Antihypertensives)IBA 11/2023 - 02/2023
2	Insulin (Novolin)FDA Link 01/2019 - 12/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2011
2	NeurograninIBA 01/2018 - 11/2016
2	Receptor for Advanced Glycation End ProductsIBA 05/2015 - 09/2014
2	Desipramine (Pertofrane)FDA LinkGeneric 12/2014 - 02/2011
2	HarmalineIBA 07/2012 - 10/2011
2	Carboxylic AcidsIBA 07/2012 - 10/2011
2	1-Octanol (1 Octanol)IBA 07/2012 - 10/2011
2	AlcoholsIBA 07/2012 - 10/2011
2	Antidepressive Agents (Antidepressants)IBA 02/2011 - 01/2008
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	tempolIBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Dantrolene (Dantrium)FDA LinkGeneric 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Recombinant ProteinsIBA 01/2019
1	Superoxides (Superoxide)IBA 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2019
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Retinaldehyde (Retinal)IBA 01/2018
1	4-Aminopyridine (4 Aminopyridine)FDA Link 08/2017
1	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 08/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2016
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2016
1	alpha-hydroxyglutarateIBA 02/2016
1	Genitourinary AgentsIBA 01/2016
1	Hormones (Hormone)IBA 09/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2014
1	Rosiglitazone (Avandia)FDA Link 12/2014
1	Pioglitazone (Actos)FDA Link 12/2014

Therapy/Procedure

9	Therapeutics 10/2023 - 12/2008
3	Thrombectomy 10/2023 - 01/2023
1	Patient Transfer (Patient Dumping) 02/2023
1	Cognitive Training 01/2020
1	Secondary Prevention 12/2019
1	Transitional Care 12/2019
1	Spinal Injections 01/2019
1	Length of Stay 01/2019
1	Catheters 01/2018
1	Contraindications 01/2017
1	Thrombolytic Therapy 10/2016